Bulk Pharmaceutical API Sources for MANNITOL 15% W/ DEXTROSE 5% IN SODIUM CHLORIDE 0.45%

Bulk Pharmaceutical API Sources for MANNITOL 15% W/ DEXTROSE 5% IN SODIUM CHLORIDE 0.45%

Vendor	Vendor Homepage	Vendor Sku	API Url
Sigma-Aldrich		M1902_SIGMA
Sigma-Aldrich		M4125_SIAL
Sigma-Aldrich		M8429_SIAL
Sigma-Aldrich		M9546_SIAL
Sigma-Aldrich		M9647_SIAL
Hangzhou Trylead Chemical Technology		TL806434
NovoSeek		6251

Bulk Active Pharmaceutical Ingredient (API) Sources for Mannitol 15% W/Dextrose 5% in Sodium Chloride 0.45%

Last updated: August 13, 2025

---

Introduction

The pharmaceutical industry relies heavily on a robust supply chain for Active Pharmaceutical Ingredients (APIs), especially for compounded formulations like Mannitol 15% w/v, Dextrose 5% w/v, in Sodium Chloride 0.45%. This specific IV admixture is commonly used in clinical settings for rehydration and electrolyte balance in patients. The quality, sourcing, and regulatory compliance of APIs substantially influence the efficacy, safety, and manufacturing continuity of such intravenous solutions.

This article examines available bulk API sources for Mannitol, Dextrose (Glucose), and Sodium Chloride, focusing on their global production hubs, regulatory statuses, quality standards, and reliability for pharmaceutical manufacturing.

---

1. Mannitol API Sources

Overview: Mannitol is a sugar alcohol used as an osmotic diuretic and excipient in pharmaceutical and medical applications. The primary sources of pharmaceutical-grade Mannitol stem from established European, American, Asian, and global chemical manufacturers.

Major Suppliers and Manufacturing Hubs

• Merck KGaA (Germany): One of the industry leaders, Merck produces high-quality Mannitol adhering to pharmacopoeial standards (USP, EP). Their facilities in Darmstadt ensure consistent supply and stringent quality control.

• Fonterra Co-operative Group (New Zealand): Supplies Mannitol with GMP certification for pharmaceutical use, supporting global markets.

• Roquette Frères (France): A major global supplier offering Mannitol for pharmaceutical and medical applications, with a focus on purity and process integrity.

• BASF SE (Germany): Produces Mannitol for pharmaceutical-grade applications, with extensive GMP compliance.

• Chinese Manufacturers: Several manufacturers such as Shandong Baoye Biological Technology and Sinopharm provide bulk Mannitol API. These suppliers often offer competitive pricing but require rigorous qualification processes to ensure pharmaceutical-grade quality and regulatory compliance (e.g., Chinese Pharmacopoeia standards).

Quality Standards and Regulatory Status

• GMP Certification: Essential for pharmaceutical APIs, ensuring compliance with regulatory requirements from agencies such as the FDA (USA), EMA (Europe), and PMDA (Japan).

• Pharmacopoeial Compatibility: Compliance with USP, EP, BP ensures batch-to-batch consistency, purity, and safety.

• Supply Reliability: Established multinationals tend to ensure supply continuity, which is critical for IV formulations.

---

2. Dextrose Monohydrate API Sources

Overview: Dextrose (glucose) is a glucose monohydrate used extensively in medical and pharmaceutical solutions. The key to sourcing Dextrose API is its adherence to high purity and safety standards.

Global Suppliers and Credentialed Manufacturers

• Cargill Inc. (USA): A major global player, supplying pharmaceutical-grade Dextrose with adherence to cGMP standards.

• Archer Daniels Midland Company (ADM) (USA): Offers high-purity Dextrose Pharma-grade APIs globally.

• Tate & Lyle (UK): Provides pharmaceutical grades, focusing on traceability and purity standards.

• Jilin Forest Industry (China): A significant Chinese manufacturer of pharmaceutical-grade Dextrose, but qualification remains critical.

• Dextrose derivatives manufacturers in India: Companies like Roquette India and Gujarat Flavours & Food Chemicals offer pharmaceutical-grade Dextrose conforming to pharmacopoeial standards.

Regulatory and Quality Considerations

• GMP Compliance: Necessary to prevent microbial contamination and impurities.

• Pharmacopoeia Standards: Most suppliers align with USP, EP, or BP standards.

• Supply Chain Reliability: Global giants such as Cargill and ADM offer assured supply chains, whereas regional players require validation.

---

3. Sodium Chloride (NaCl) API Sources

Overview: Pharmaceutical-grade Sodium Chloride serves as an essential electrolyte and is predominantly sourced from mineral extraction and refinement processes.

Leading Suppliers and Regions

• Halliburton (USA) and Johnson Matthey (UK): Historically involved in salt production for pharma use, focusing on purity.

• Yara International (Norway): Manufactures high-purity Sodium Chloride suitable for IV use.

• Shandong Luyuan Salt Industry Co. Ltd. (China): Produces pharmaceutical-grade Sodium Chloride fulfilling WHO and GMP standards.

• Indian Suppliers: Companies like Ballarpur Industries Ltd., and Vapi Salt Works manufacture pharmaceutical-grade NaCl.

Quality and Certification Standards

• GMP Certification: Vital for injectable solutions, ensuring low endotoxin and microbial contamination.

• BP, USP, EP Compliance: Confirmed for injection use, with stringent endotoxin and microbial limits.

• Quality Assurance: Suppliers with ISO certifications and regulatory approvals minimize risks in manufacturing.

---

4. Key Considerations for API Sourcing

Quality and Regulatory Compliance:
Ensuring APIs meet pharmacopoeial standards and hold certifications such as GMP, ISO, and certificate of analysis (CoA) is imperative. A validated supplier reduces regulatory hurdles and supply chain risks.

Supply Chain and Reliability:
Engagement with established, reputable suppliers with proven logistics networks minimizes manufacturing disruptions and ensures consistent API availability.

Cost vs. Quality Balance:
While Asian manufacturers often offer competitive pricing, rigorous qualification, and validation processes are necessary to confirm compliance with international quality standards.

Vendor Qualification and Audits:
Due diligence, including auditing manufacturing facilities and reviewing quality documentation, remains critical for API procurement, especially for sterile and injectable formulations.

---

Conclusion

The successful sourcing of APIs for Mannitol 15%, Dextrose 5%, and Sodium Chloride 0.45% requires navigating a complex landscape of global suppliers. Industry-leading pharmaceutical API manufacturers from North America, Europe, and Asia offer high-quality, regulated API sources. Multinational suppliers such as Merck, Cargill, Archer Daniels Midland, and Yara provide reliable quality and regulatory compliance essential for sterile injectable formulations. Regional manufacturers can supplement supply but necessitate supplementary validation.

Established vendor qualification processes and adherence to cGMP, pharmacopoeial standards, and quality certifications are paramount to ensure product safety, efficacy, and ongoing supply chain stability.

---

Key Takeaways

• Prioritize sourcing APIs from globally recognized manufacturers with established GMP compliance, ensuring consistent quality for sterile IV solutions.
• Maintain a qualification program that verifies supplier certifications, quality standards, and regulatory compliance.
• Utilize regional suppliers strategically, but include validation and qualification steps to mitigate quality and supply risks.
• Regularly review supplier performance, audit manufacturing facilities, and stay updated on evolving regulatory standards.
• Building a diverse supplier network enhances resilience, safeguards supply continuity, and optimizes procurement costs.

---

5 Unique FAQs

Q1: What are the critical quality attributes of APIs used in IV formulations like Mannitol, Dextrose, and Sodium Chloride?

A1: Critical attributes include high purity (free from microbial and endotoxin contamination), consistent batch-to-batch composition, adherence to pharmacopoeial standards (USP, EP), and compliance with GMP. Also, the APIs should be free from heavy metals and other impurities that could compromise patient safety.

Q2: How can manufacturers verify the quality of regional or emerging API suppliers?

A2: Verification involves reviewing supplier certifications (GMP, ISO), conducting comprehensive audits, evaluating CoA documentation, performing analytical testing of initial batches, and validating supply chain integrity, including traceability and batch consistency.

Q3: Are there specific regulatory challenges when sourcing APIs globally?

A3: Yes. Different jurisdictions have varying standards. Regulatory challenges include ensuring API suppliers meet regional compliance requirements (like FDA, EMA, or Indian Drugs Controller), managing import/export restrictions, and maintaining documentation for regulatory submissions.

Q4: What role does API sourcing play in ensuring the safety of IV formulations?

A4: API sourcing directly impacts formulation safety by influencing purity levels, microbial and endotoxin limits, and overall product stability. Substandard APIs increase risks of adverse reactions or manufacturing failures, emphasizing strict supplier qualification.

Q5: How does supply chain diversification mitigate risks associated with API procurement?

A5: Diversification prevents over-reliance on a single supplier or region. It mitigates risks from geopolitical disruptions, natural disasters, or manufacturing setbacks, ensuring continuous production and supply of critical IV solutions.

---

Sources:

1. [1] European Pharmacopoeia, Monograph on Mannitol.
2. [2] United States Pharmacopeia, Monograph on Dextrose, USP.
3. [3] World Health Organization, Quality Standards for Pharmaceutical Salt.
4. [4] Industry reports on global API manufacturing hubs.
5. [5] Regulatory agency guidelines (FDA, EMA) for API sourcing.